Home › Funds › New Vernon Capital Holdings II LLC › COLL
New Vernon Capital Holdings II LLC position in COLL
COLLEGIUM PHARMACEUTICAL INC · Health Care
New Vernon Capital Holdings II LLC reported holding 5,343 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q2 2026 13F filing — a position valued at US$193K, representing 0.11% of its reported portfolio and ranking #50 among its reported holdings. New Vernon Capital Holdings II LLC has disclosed COLL holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How New Vernon Capital Holdings II LLC's COLL position evolved
New Vernon Capital Holdings II LLC first disclosed a stake in COLL in Q1 2024 at 3,400 shares (US$132K). The position peaked in Q4 2025 at 5,343 shares, worth US$247K. Across 7 filings, New Vernon Capital Holdings II LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 5,343 shares valued at US$193K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 3.40K | $131.99K | New |
| Q2 2024 | 3.40K | $109.48K | Hold |
| Q3 2024 | 3.40K | $131.38K | Hold |
| Q3 2025 | 5.34K | $186.95K | New |
| Q4 2025 | 5.34K | $247.38K | Hold |
| Q1 2026 | 5.34K | $176.69K | Hold |
| Q2 2026 | 5.34K | $193.42K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COLL and 13F data
COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 33 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), EVENTIDE ASSET MANAGEMENT, LLC (US$49.3M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COLL
- TENOR CAPITAL MANAGEMENT Co., L.P. 68.81M sh · $85.79M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.36M sh · $49.27M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 744.89K sh · $26.92M · Q2 2026
- SILVERBACK ASSET MANAGEMENT LLC 15.30M sh · $18.79M · Q2 2026
More on New Vernon Capital Holdings II LLC
FAQ
How long has New Vernon Capital Holdings II LLC held COLL?
New Vernon Capital Holdings II LLC has disclosed COLL holdings in 7 of the last 10 reported quarters, going back to Q1 2024.
What is New Vernon Capital Holdings II LLC's current position in COLL?
As of Q2 2026, New Vernon Capital Holdings II LLC holds 5.34K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $193.42K, representing 0.11% of its reported portfolio and ranking #50.
Has New Vernon Capital Holdings II LLC been buying or selling COLL?
In the latest 13F filing (Q2 2026), New Vernon Capital Holdings II LLC held unchanged its position in COLL. The position peaked in Q4 2025 at 5.34K shares.
Which other funds hold COLL?
Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., EVENTIDE ASSET MANAGEMENT, LLC, GOLDENTREE ASSET MANAGEMENT LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.